Solara Active Pharma Sciences Limited has submitted the Exchange a copy Scrutinizer's report and Voting Results of the 8th Annual General Meeting held on September 25, 2025
SOLARA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Solara Active Pharma Sciences held its 8th AGM on September 25, 2025, via video conferencing from 10:30 AM to 11:02 AM, with a total of 73,100 shareholders on record. All six resolutions were passed with overwhelming majority. These included adoption of audited financial statements for FY25 (99.9996% in favor), appointment of Mr. Mohan Muthunarayanan as Executive Director (99.98%) and Mr. Manish Gupta as Non-Executive Director (99.99%), ratification of Cost Auditor remuneration for FY26 (99.97%), and appointment of Secretarial Auditor (99.99%). A key resolution approving material related party transactions with Strides Pharma Science Limited worth up to Rs. 400 crores was also passed with 99.87% support, though promoter group shares (1.07 crore) were excluded from voting as they are related parties. The scrutinizer, Preetham Hebbar & Co., confirmed the voting process was conducted fairly in line with SEBI and Companies Act rules.
All AGM resolutions were approved with near-unanimous support, indicating strong shareholder confidence in management. The approval of up to Rs. 400 crore in related party transactions with Strides Pharma is notable — investors should monitor these transactions for related-party governance, though promoter abstention from voting on that specific item is a standard compliance practice.